Characterization of post-COVID-19 Guillain-Barré syndrome in a private clinic in the inner Amazon – case series report
DOI:
https://doi.org/10.33448/rsd-v11i15.37532Keywords:
Guillain-Barré Syndrome; COVID-19; SARS-CoV-2.Abstract
Objectives: to report cases of post-COVID-19 Guillain-Barré Syndrome in a city in the interior of the Amazon, to characterize the evolution of the clinical picture, diagnosis and outcome of the disease, to portray the similarities and differences between patients and to highlight the importance of valuing the Post-COVID-19 Guillain-Barré Syndrome. Methods: this is a case series composed of six patients with a condition compatible with Guillain-Barré Syndrome related to previous infection by COVID-19. It is an observational and descriptive study and the data were collected retrospectively from the analysis of the medical records of a private clinic located in Santarém, state of Pará, Brazil. Results and Discussion: All patients had a clinical and laboratory diagnosis of COVID-19, followed by Guillain-Barré Syndrome. In this study, motor impairment was predominant and did not always follow an ascending pattern. The cerebrospinal fluid (CSF) examination had a variable result and without the typical abnormalities. Electroneuromyography revealed that axonal involvement was predominant. Most patients evolved with functional recovery and only one of them presented no improvement. Treatment with intravenous immunoglobulin appears to have contributed to a positive outcome. The data found are compatible with studies in other regions of the world. Conclusion: Post-COVID-19 Guillain-Barré Syndrome may have different clinical, laboratory and neurophysiological manifestations than usual and may have a variable course, with early diagnosis being essential for a more assertive treatment and lower risk of sequelae. This has become a challenge in remote places and small towns in the Amazon, where access to health care is more precarious.
References
Bonita, R., Beaglehole, R., & Kjellstrom, T. (2010). Epidemiologia básica (2ªed.). São Paulo: Santos. https://ria.ufrn.br/jspui/handle/123456789/1006
Brasil. (2020). Protocolo de Manejo Clínico do Coronavírus (COVID-19) na Atenção Primária à Saúde. Secretaria de Atenção Primária à Saúde (SAPS), 9, 1–41. https://portaldeboaspraticas.iff.fiocruz.br/biblioteca/protocolo-de-manejo-clinico-do-coronavirus-covid-19-na-atencao-primaria-a-saude/
Brasil. (2022). Secretaria de Vigilância à Saúde (SVS): Guia de vigilância Epidemiológica. Ministério da Saúde. Coronavírus Brasil (covid.saude.gov.br).
Brooks, J. E., Mix, F. M., Buck, J. C., & Walters, R. A. (2021). COVID-19-Induced Guillain-Barré Syndrome. Cureus, 13(11), 11–13. https://doi.org/10.7759/cureus.19809
Burns, T. M. (2008). Guillain-Barré syndrome. Seminars in Neurology, 28(2), 152–167. https://doi.org/10.1055/s-2008-1062261
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
Doets, A. Y., Verboon, C., van den Berg, B., Harbo, T., Cornblath, D. R., Willison, H. J., Islam, Z., Attarian, S., Barroso, F. A., Bateman, K., Benedetti, L., van den Bergh, P., Casasnovas, C., Cavaletti, G., Chavada, G., Claeys, K. G., Dardiotis, E., Davidson, A., van Doorn, P. A., … Zivkovic, S. (2018). Regional variation of Guillain-Barré syndrome. Brain, 141(10), 2866–2877. https://doi.org/10.1093/brain/awy232
Fokke, C., Van Den Berg, B., Drenthen, J., Walgaard, C., Van Doorn, P. A., & Jacobs, B. C. (2014). Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain, 137(1), 33–43. https://doi.org/10.1093/brain/awt285
Hahn, A. F. (1998). Guillain-Barre syndrome. Lancet, 352(9128), 635–641. https://doi.org/10.1016/S0140-6736(97)12308-X
Hochman, B., Nahas F.X., Filho R.S.O., Ferreira L.M.F. Desenhos de pesquisa. Acta Cirúrgica Brasileira. 2005; 20 (2): 2-9
Honorato, M. M., Silva, F. L. L. da, Santos, A. C. V. dos, Silva, J. F. da, Cremaschi, R. M. de C., & Coelho, F. M. S. (2021). Covid-19: an Emerging Cause of Acute Cerebelitis in Adults? International Journal of Health Science, 1(3), 2–5. https://doi.org/10.22533/at.ed.1592120107
Jin, P. P., Sun, L. L., Ding, B. J., Qin, N., Zhou, B., Xia, F., Li, L., Liu-, L. J., Liu, X. D., Zhao, G., Wang, W., Deng, Y. C., & Hou, S. X. (2015). Human leukocyte antigen DQB1 (HLADQB1) polymorphisms and the risk for Guillain-Barré syndrome: A systematic review and meta-analysis. PLoS ONE, 10(7), 1–14. https://doi.org/10.1371/journal.pone.0131374
Kieseier, B. C., & Hartung, H. P. (2003). Therapeutic strategies in the Guillain-Barré syndrome. Seminars in Neurology, 23(2), 159–167. https://doi.org/10.1055/s-2003-41132
Li, X., Wang, Y., Wang, H., & Wang, Y. (2021). SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease. Qjm, 114(9), 625–635. https://doi.org/10.1093/qjmed/hcab157
McGann, J. P., & Bahuva, R. (2021). Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a Patient Presenting With Guillain-Barré Syndrome. Cureus, 13(10), 2–5. https://doi.org/10.7759/cureus.19147
Mendoza, D; Blancas, L y Gutiérrez, J. (2010). Artículo de revisión: Síndrome de Guillain - Barré. Alergia, Asma e Inmunología Pediátricas., 19(2), 56-63. https://www.medigraphic.com/pdfs/alergia/al-2010/al102c.pdf
Nunes, M. J. M., Carlos, J., Silva, S., Oliveira, C. De, Victor, G., & Medeiros, T. De. (2020). Alterações Neurológicas na Covid-19: uma Revisão Sistemática. Revista Neurociências, 28, 1–22. https://doi.org/10.34024/rnc.2020.v28.10949
Ousseiran, Z. H., Fares, Y., & Chamoun, W. T. (2021). Neurological manifestations of COVID-19: a systematic review and detailed comprehension. International Journal of Neuroscience, 0(0), 1–16. https://doi.org/10.1080/00207454.2021.1973000
Randhawa, J., Randhawa, H. S., & Toor, P. (2021). Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome in a Patient of COVID-19 Infection. Cureus, 13(9), 2–9. https://doi.org/10.7759/cureus.17945
Silva, R. P. A. da. (2015). SÍNDROME DE GUILLAIN-BARRÉ Revisão retrospetiva da casuística dos casos hospitalizados no Centro Hospitalar do Porto. Monografia (Programa de mestrado integrado em medicina) -Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto. https://repositorio-aberto.up.pt/bitstream/10216/81939/2/37653.pdf
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barre´ syndrome associated with SARS-CoV-2. N Engl J Med 2020; 382:2574–6. https://www.nejm.org/doi/10.1056/NEJMc2009191
Umakanthan, S., Sahu, P., Ranade, A. V., Bukelo, M. M., Rao, J. S., Abrahao-Machado, L. F., Dahal, S., Kumar, H., & Kv, D. (2020). Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgraduate Medical Journal, 96(1142), 753–758. https://doi.org/10.1136/postgradmedj-2020-138234
Verboon, C., Van Doorn, P. A., & Jacobs, B. C. (2017). Treatment dilemmas in Guillain-Barré syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 88(4), 346–352. https://doi.org/10.1136/jnnp-2016-314862
Vucic, S., Kiernan, M. C., & Cornblath, D. R. (2009). Guillain-Barré syndrome: An update. Journal of Clinical Neuroscience, 16(6), 733–741. https://doi.org/10.1016/j.jocn.2008.08.033
Walling, A. D., & Dickson, G. (2013). Guillain-Barré syndrome. American family physician, 87(3), 191–197.
WHO. (2021). Living Guidance for clinical management of COVID-19. World Health Organization, November, 63. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016). Guillain-Barré syndrome. The Lancet, 388(10045), 717–727. https://doi.org/10.1016/S0140-6736(16)00339-1
Xavier, A. R., Silva, J. S., Almeida, J. P. C. L., Conceição, J. F. F., Lacerda, G. S., & Kanaan, S. (2020). COVID-19: manifestações clínicas e laboratoriais na infecção pelo novo coronavírus. Jornal Brasileiro de Patologia e Medicina Laboratorial, 56(5), 1–9.
Yüce, M., Filiztekin, E., & Özkaya, K. G. (2021). COVID-19 diagnosis —A review of current methods. Biosensors and Bioelectronics, 172, 112752. https://doi.org/10.1016/J.BIOS.2020.112752
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Eyran Joshua Sobrinho de Sousa; Emily Andreza Moreira Navarro; Marcos Manoel Honorato; Renata Carvalho Cremaschi; Fernando Morgadinho Santos Coelho
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
